Atara Biotherapeutics, Inc.  (ATRA)
Other Ticker:  
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Cumulative Atara Biotherapeutics's Quick Ratio for Trailing Twelve Months Period

ATRA's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth

ATRA Quick Ratio for Trailing Twelve Months Period

(Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
(Jun 30 2018)
II. Quarter
(Mar 31 2018)
I. Quarter
Y / Y Current Liabilities Growth 71.11 % -12.14 % 40.45 % 79.19 % 88.51 %
Y / Y Cash & cash equivalent Growth -41.71 % 86.42 % 81.99 % 92.18 % 76.54 %
Quick Ratio for Trailing Twelve Months Period 14.82 18.92 16.51 15.79 14.94
Total Ranking # # # # #
Seq. Current Liabilities Growth 21.21 % -10.47 % 12.75 % 39.83 % -37.76 %
Seq. Cash & cash equivalent Growth -23.28 % -15.11 % -12.58 % 2.38 % 145.35 %

Quick Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to growth in Current Liabilities in the I. Quarter to $25 millions, average cumulative Quick Ratio for Trailing Twelve Months Period decreased to 14.82 above Atara Biotherapeutics, Inc. average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Biotechnology & Drugs industry Atara Biotherapeutics, Inc. achieved highest Quick Ratio for Trailing Twelve Months Period. While overall ranking remained unchanged compare to previous quarter at no. .

What is Quick Ratio?
Learn more about ATRA
Quick Ratio ATRA in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry #
Sector #
S&P 500 # 0

Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
0 0 0

Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Mar 31 2019, within Biotechnology & Drugs Industry Quick Ratio for Trailing Twelve Months Period
Eidos Therapeutics, Inc.  37.81 
Catalyst Biosciences, Inc.  34.81 
Nexien Biopharma, Inc.  29.77 
Iovance Biotherapeutics, Inc.  24.97 
Nymox Pharmaceutical Corporation  22.55 
Casi Pharmaceuticals, Inc.  22.46 
G1 Therapeutics, Inc.  21.81 
Voyager Therapeutics, Inc.  20.63 
Fennec Pharmaceuticals Inc.  20.55 
Acceleron Pharma Inc  18.78 
Audentes Therapeutics, Inc.  17.79 
Evelo Biosciences, Inc.  17.51 
Crispr Therapeutics Ag  17.48 
Regenxbio Inc.  17.14 
Atara Biotherapeutics, Inc.  16.89 
Microbot Medical Inc.  16.73 
Aravive, Inc.  16.58 
Gtx Inc  16.38 
Vical Inc  16.29 
Arcus Biosciences, Inc.  15.87 
Pulse Biosciences, Inc.  15.62 
Unity Biotechnology, Inc.  14.88 
Urogen Pharma Ltd.  14.69 
Homology Medicines, Inc.  14.42 
Eyenovia, Inc.  14.01 
Denali Therapeutics Inc.  13.65 
Scpharmaceuticals Inc.  13.33 
Allena Pharmaceuticals, Inc.  12.67 
Enzon Pharmaceuticals, Inc.  12.45 
Aerpio Pharmaceuticals, Inc.  12.44 


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production


Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales


Event Calendar

CCGN's Profile

Stock Price

CCGN's Financials

Business Description


Charts & Quotes

CCGN's News


CCGN's Competitors

Customers & Markets

Economic Indicators

CCGN's Growth

Company Segments


Stock Performance

Growth Rates




Financial Strength


Largest Companies

Management Effectivness


At a Glance


Growth Rates



Financial Strength


At a Glance



Sectors & Industries





At a Glance








About us


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071